Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research

被引：3
|
作者：
Ning, Li [1 ,2 ]
Xi, Jiahui [1 ,2 ]
Zi, Yin [1 ,2 ]
Chen, Min [1 ,2 ]
Zou, Qingjian [1 ,2 ]
Zhou, Xiaoqing [1 ,2 ]
Tang, Chengcheng [1 ,2 ]
机构：
[1] Wuyi Univ, South China Inst Large Anim Models Biomed, Sch Biotechnol & Hlth Sci, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen 529000, Peoples R China
[2] Int Healthcare Innovat Inst Jiangmen, Jiangmen, Peoples R China
来源：
CLINICAL GENETICS | 2023年 / 104卷 / 06期
关键词：
cancer; gene-editing; CRISPR/Cas9; gene therapy; immunotherapy; T-CELLS; CAS9; RIBONUCLEOPROTEIN; GENOMIC DNA; DELIVERY; BASE; IDENTIFICATION; BACTERIA; EFFICACY; REPEATS; SYSTEMS;
D O I：
10.1111/cge.14424
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Cancer, one of the leading causes of death, usually commences and progresses as a result of a series of gene mutations and dysregulation of expression. With the development of clustered regularly interspaced palindromic repeat (CRISPR)/Cas9 gene-editing technology, it is possible to edit and then decode the functions of cancer-related gene mutations, markedly advance the research of biological mechanisms and treatment of cancer. This review summarizes the mechanism and development of CRISPR/Cas9 gene-editing technology in recent years and describes its potential application in cancer-related research, such as the establishment of human tumor disease models, gene therapy and immunotherapy. The challenges and future development directions are highlighted to provide a reference for exploring pathological mechanisms and potential treatment protocols of cancer.
引用
收藏
页码：613 / 624
页数：12
相关论文
共 50 条
  • [1] Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies
    Kang, Xianhui
    Wang, Yijian
    Liu, Pan
    Huang, Baojun
    Zhou, Baofeng
    Lu, Shufang
    Geng, Wujun
    Tang, Hongli
    CANCERS, 2023, 15 (02)
  • [2] Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
    Shijing Yu
    Ruirui Zhao
    Bingchen Zhang
    Chunmei Lai
    Linyan Li
    Jiangwen Shen
    Xiarong Tan
    Jingwei Shao
    Asian Journal of Pharmaceutical Sciences, 2023, 18 (04) : 3 - 23
  • [3] Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
    Yu, Shijing
    Zhao, Ruirui
    Zhang, Bingchen
    Lai, Chunmei
    Li, Linyan
    Shen, Jiangwen
    Tan, Xiarong
    Shao, Jingwei
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 18 (04)
  • [4] A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
    Roshanravan, Neda
    Tutunchi, Helda
    Najafipour, Farzad
    Dastouri, Mohammadreza
    Ghaffari, Samad
    Jebeli, Alireza
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2022, 14 (02) : 77 - 83
  • [5] Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Ziyi Zhao
    Chenxi Li
    Fei Tong
    Jingkuang Deng
    Guofu Huang
    Yi Sang
    Biological Procedures Online, 23
  • [6] Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Zhao, Ziyi
    Li, Chenxi
    Tong, Fei
    Deng, Jingkuang
    Huang, Guofu
    Sang, Yi
    BIOLOGICAL PROCEDURES ONLINE, 2021, 23 (01)
  • [7] CRISPR/Cas9 gene-editing strategies in cardiovascular cells
    Vermersch, Eva
    Jouve, Charlene
    Hulot, Jean-Sebastien
    CARDIOVASCULAR RESEARCH, 2020, 116 (05) : 894 - 907
  • [8] CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
    Memi, Fani
    Ntokou, Aglaia
    Papangeli, Irinna
    SEMINARS IN PERINATOLOGY, 2018, 42 (08) : 487 - 500
  • [9] Establishment of a CRISPR/Cas9 gene-editing system for Chrysanthemum morifolium
    Chen, Qi
    Zhang, Xin
    Jin, Ruibing
    Mao, Hongyu
    ORNAMENTAL PLANT RESEARCH, 2024, 4
  • [10] CRISPR/Cas9: Prospects and Challenges
    Zhang, Feng
    HUMAN GENE THERAPY, 2015, 26 (07) : 409 - 410
12345